Class Action Lawsuit Against Eli Lilly and Company Regarding Cymbalta

October 31, 2012

Keller Rohrback L.L.P., Keller Rohrback P.L.C., Pogust Braslow Millrood LLC and Deskin Law Firm, a PLC filed a class action lawsuit today against Eli Lilly and Company (“Lilly”) (NYSE:LLY). Lilly, an Indiana based pharmaceutical company, is the maker of Cymbalta. The class action complaint was filed in the United States District Court for the Central District of California, in Los Angeles, on behalf of all consumers who purchased Cymbalta at any time since the product’s launch in August 2004 to the present.

Cymbalta is prescribed to individuals that have been diagnosed with generalized anxiety disorder, fibromyalgia, and musculoskeletal pain. Plaintiff alleges that Lilly misrepresented the risks associated with taking Cymbalta and misled consumers about the frequency, severity, and duration of “Cymbalta withdrawal.” Withdrawal symptoms include, among others, headaches, dizziness, nausea, fatigue, nightmares, insomnia, anxiety, and suicidal ideation. Cymbalta withdrawal symptoms can range from mild to severe—the latter consisting of debilitating and painful symptoms that last several months.

If you used Cymbalta or you would like more information regarding the Cymbalta class action, please contact one of the following attorneys: Michael Woerner or Mark Samson, Keller Rohrback at 800-776-6044.

If you used Cymbalta, suffered serious side effects, and want more information about pursuing an individual personal injury claim, please contact Pogust Braslow Millrood LLC and Deskin Law Firm, a PLC via the contact form on this website or at 800-897-8930.

Contact Cymbalta Attorneys

Cymbalta LawyersOur firms are investigating problems with symptoms from the discontinuation of use of Cymbalta. Please use the form below to tell us about your situation. We will contact you by phone as soon as possible.

Your confidentiality matters. No information, including phone numbers and email addresses will be exchanged, shared or sold to a third party. Any communications to our firm via contact forms, email, phone or U.S. mail, will be treated confidentially. Submissions are made for the purpose of evaluating whether or not our law firm will accept your case and represent you. However, all information contained in your submission will be held confidential. By evaluating your submission we make no representation or agreement to represent you in connection with your claim. Thank you.

Please type your full street address including your city, state and postal code
Approximate date Cymbalta was prescribed to you
Approximate date you stopped using Cymbalta